The fund will primarily invest in medical device, diagnostic, and digital health companies.
Cross-Border Impact Ventures (CBIV), a Canada-based venture capital firm, has raised $30m in the initial close of its Women’s and Children’s Health Technology Fund.
The fund will primarily invest in medical device, diagnostic, and digital health companies based in North America, Europe, and Israel. Its secondary focus is on commercial stage companies in emerging markets with global technology transfer potential.
CBIV is targeting more than $100m for the fund, which has an undisclosed strategic healthcare as a limited partner (LP).
Its disclosed LPs include Children’s Investment Fund Foundation, Global Health Investment Corporation (with the financial support of the German government through its KfW Development Bank), Grand Challenges Canada, Hamilton Community Foundation, Rally Total Impact Fund, RockCreek, and Sida – the Swedish International Development Cooperation Agency, which provides a guarantee to investors in the fund to encourage private sector participation in the firm’s impact investing strategy.
The fund will use a gender lens to invest and will work with…
